![]() |
|
|
3 Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, 751 85 Uppsala, Sweden and 4 Department of Food Science, the Swedish University of Agriculture Sciences (SLU), 750 07 Uppsala, Sweden
* To whom correspondence should be addressed. E-mail: agneta.andersson{at}pubcare.uu.se.
High intakes of whole grain foods are inversely related to the incidence of coronary heart diseases and type 2 diabetes, but the mechanisms remain unclear. Our study aimed to evaluate the effects of a diet rich in whole grains compared with a diet containing the same amount of refined grains on insulin sensitivity and markers of lipid peroxidation and inflammation. In a randomized crossover study, 22 women and 8 men (BMI 28 ± 2) were given either whole-grain or refined-grain products (3 bread slices, 2 crisp bread slices, 1 portion muesli, and 1 portion pasta) to include in their habitual daily diet for two 6-wk periods. Peripheral insulin sensitivity was determined by euglycemic hyperinsulinemic clamp tests. 8-Iso-prostaglandin F2
(8-iso PGF2
), an F2-isoprostane, was measured in the urine as a marker of lipid peroxidation, and highly sensitive C-reactive protein and IL-6 were analyzed in plasma as markers of inflammation. Peripheral insulin sensitivity [mg glucose · kg body wt1 · min1 per unit plasma insulin (mU/L) x 100] did not improve when subjects consumed whole-grain products (6.8 ± 3.0 at baseline and 6.5 ± 2.7 after 6 wk) or refined products (6.4 ± 2.9 and 6.9 ± 3.2, respectively) and there were no differences between the 2 periods. Whole-grain consumption also did not affect 8-iso-PGF2
in urine, IL-6 and C-reactive protein in plasma, blood pressure, or serum lipid concentrations. In conclusion, substitution of whole grains (mainly based on milled wheat) for refined-grain products in the habitual daily diet of healthy moderately overweight adults for 6-wk did not affect insulin sensitivity or markers of lipid peroxidation and inflammation.
This article has been cited by other articles:
![]() |
F. F. De Moura, K. D. Lewis, and M. C. Falk Applying the FDA Definition of Whole Grains to the Evidence for Cardiovascular Disease Health Claims J. Nutr., November 1, 2009; 139(11): 2220S - 2226S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Landberg, A. Kamal-Eldin, A. Andersson, B. Vessby, and P. Aman Alkylresorcinols as biomarkers of whole-grain wheat and rye intake: plasma concentration and intake estimated from dietary records Am. J. Clinical Nutrition, April 1, 2008; 87(4): 832 - 838. [Abstract] [Full Text] [PDF] |
||||